1. Home
  2. /
  3. News center
  4. /
  5. BioNet News
  6. /
  7. BioNet’s vaccine study featured...
June 20, 2024 Supachai

BioNet’s vaccine study featured at AOFOG 2024

At this year’s 28th Asia and Oceania Federation of Obstetrics and Gynecology Congress (AOFOG 2024 Congress in Busan, Korea), themed “Quantum Leap for Women’s Health in Asia and Oceania,” BioNet delivered an impactful presentation. Our E-Poster received attention for its pioneering approach to maternal immunization, titled “Immunization of Pregnant Women with Full- and Reduced-Dose Recombinant Acellular Pertussis Vaccines Induces High Levels of Passive Immunity in Infants in Thailand”. Aligned perfectly with the conference’s theme, our presentation highlighted critical advancements in vaccine research aimed at protecting maternal and infant from pertussis.

We extend our sincere appreciation to Dr. Surasith Chaithongwongwatthana for his efforts in presenting our study at the conference, helping to share our work with a broader audience of experts and professionals in obstetrics and gynecology. His support has been invaluable in promoting our research and contributing to vaccine development, aiming to make significant progress in women’s health across Asia and Oceania.